annual operating profit:
$474.21M+$316.12M(+199.95%)Summary
- As of today (July 1, 2025), BMRN annual operating income is $474.21 million, with the most recent change of +$316.12 million (+199.95%) on December 31, 2024.
- During the last 3 years, BMRN annual operating profit has risen by +$548.55 million (+737.96%).
- BMRN annual operating profit is now at all-time high.
Performance
BMRN Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
$223.91M+$62.54M(+38.75%)Summary
- As of today (July 1, 2025), BMRN quarterly operating income is $223.91 million, with the most recent change of +$62.54 million (+38.75%) on March 31, 2025.
- Over the past year, BMRN quarterly operating profit has increased by +$145.44 million (+185.35%).
- BMRN quarterly operating profit is now at all-time high.
Performance
BMRN quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
$619.61M+$145.44M(+30.67%)Summary
- As of today (July 1, 2025), BMRN TTM operating income is $619.61 million, with the most recent change of +$145.44 million (+30.67%) on March 31, 2025.
- Over the past year, BMRN TTM operating profit has increased by +$374.58 million (+152.87%).
- BMRN TTM operating profit is now at all-time high.
Performance
BMRN TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
BMRN Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +199.9% | +185.3% | +152.9% |
| 3 y3 years | +738.0% | +614.8% | +979.6% |
| 5 y5 years | +552.4% | +393.1% | +6121.6% |
BMRN Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +738.0% | at high | +1897.5% | at high | +1501.3% |
| 5 y | 5-year | at high | +552.4% | at high | +448.6% | at high | +666.7% |
| alltime | all time | at high | +268.5% | at high | +349.8% | at high | +308.9% |
BMRN Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $223.91M(+38.8%) | $619.61M(+30.7%) |
| Dec 2024 | $474.21M(+199.9%) | $161.37M(+41.7%) | $474.16M(+39.4%) |
| Sep 2024 | - | $113.87M(-5.5%) | $340.10M(+13.4%) |
| Jun 2024 | - | $120.45M(+53.5%) | $299.92M(+22.4%) |
| Mar 2024 | - | $78.47M(+187.4%) | $245.03M(+7.0%) |
| Dec 2023 | $158.10M(+244.0%) | $27.30M(-63.0%) | $228.97M(+21.0%) |
| Sep 2023 | - | $73.69M(+12.4%) | $189.21M(+65.9%) |
| Jun 2023 | - | $65.57M(+5.1%) | $114.04M(+28.8%) |
| Mar 2023 | - | $62.40M(-601.0%) | $88.53M(+54.1%) |
| Dec 2022 | $45.96M(-161.8%) | -$12.46M(+745.7%) | $57.45M(+912.5%) |
| Sep 2022 | - | -$1.47M(-103.7%) | $5.67M(-112.8%) |
| Jun 2022 | - | $40.05M(+27.9%) | -$44.22M(-37.2%) |
| Mar 2022 | - | $31.33M(-148.8%) | -$70.44M(-5.2%) |
| Dec 2021 | -$74.33M(-19.1%) | -$64.23M(+25.1%) | -$74.33M(+43.3%) |
| Sep 2021 | - | -$51.36M(-471.6%) | -$51.89M(-4.9%) |
| Jun 2021 | - | $13.82M(-49.6%) | -$54.59M(-50.1%) |
| Mar 2021 | - | $27.44M(-165.7%) | -$109.34M(+19.7%) |
| Dec 2020 | -$91.83M(-12.4%) | -$41.79M(-22.7%) | -$91.37M(+89.9%) |
| Sep 2020 | - | -$54.06M(+32.1%) | -$48.11M(-583.1%) |
| Jun 2020 | - | -$40.93M(-190.1%) | $9.96M(-284.2%) |
| Mar 2020 | - | $45.41M(+2989.3%) | -$5.41M(-94.8%) |
| Dec 2019 | -$104.83M(-32.4%) | $1.47M(-63.3%) | -$104.77M(-32.8%) |
| Sep 2019 | - | $4.01M(-107.1%) | -$155.90M(-11.2%) |
| Jun 2019 | - | -$56.30M(+4.4%) | -$175.65M(+6.7%) |
| Mar 2019 | - | -$53.95M(+8.6%) | -$164.62M(+6.2%) |
| Dec 2018 | -$155.04M(+11.0%) | -$49.66M(+215.5%) | -$155.04M(-10.0%) |
| Sep 2018 | - | -$15.74M(-65.2%) | -$172.33M(+1.2%) |
| Jun 2018 | - | -$45.26M(+2.0%) | -$170.31M(+3.9%) |
| Mar 2018 | - | -$44.37M(-33.7%) | -$163.86M(+17.3%) |
| Dec 2017 | -$139.70M(-31.6%) | -$66.95M(+387.7%) | -$139.70M(-14.0%) |
| Sep 2017 | - | -$13.73M(-64.6%) | -$162.37M(-22.2%) |
| Jun 2017 | - | -$38.81M(+92.1%) | -$208.73M(+45.4%) |
| Mar 2017 | - | -$20.21M(-77.5%) | -$143.60M(-29.7%) |
| Dec 2016 | -$204.31M(-27.4%) | -$89.62M(+49.2%) | -$204.31M(+10.9%) |
| Sep 2016 | - | -$60.09M(-328.4%) | -$184.17M(-10.6%) |
| Jun 2016 | - | $26.31M(-132.5%) | -$205.96M(-30.6%) |
| Mar 2016 | - | -$80.92M(+16.5%) | -$296.56M(+5.3%) |
| Dec 2015 | -$281.50M(+75.5%) | -$69.48M(-15.1%) | -$281.50M(+4.0%) |
| Sep 2015 | - | -$81.87M(+27.4%) | -$270.78M(+10.4%) |
| Jun 2015 | - | -$64.29M(-2.4%) | -$245.20M(+22.7%) |
| Mar 2015 | - | -$65.86M(+12.1%) | -$199.79M(+24.6%) |
| Dec 2014 | -$160.39M(+3.4%) | -$58.76M(+4.4%) | -$160.39M(+4.8%) |
| Sep 2014 | - | -$56.30M(+198.2%) | -$153.01M(+3.8%) |
| Jun 2014 | - | -$18.88M(-28.6%) | -$147.43M(-0.8%) |
| Mar 2014 | - | -$26.46M(-48.5%) | -$148.60M(-4.2%) |
| Dec 2013 | -$155.07M(+40.7%) | -$51.37M(+1.3%) | -$155.07M(+3.0%) |
| Sep 2013 | - | -$50.72M(+153.0%) | -$150.60M(+36.5%) |
| Jun 2013 | - | -$20.05M(-39.1%) | -$110.37M(-9.0%) |
| Mar 2013 | - | -$32.92M(-29.8%) | -$121.27M(+10.0%) |
| Dec 2012 | -$110.22M(+225.2%) | -$46.90M(+347.1%) | -$110.22M(+30.1%) |
| Sep 2012 | - | -$10.49M(-66.1%) | -$84.75M(-5.6%) |
| Jun 2012 | - | -$30.95M(+41.6%) | -$89.77M(+46.3%) |
| Mar 2012 | - | -$21.87M(+2.0%) | -$61.37M(+66.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$33.89M(-6329.8%) | -$21.43M(+38.1%) | -$36.90M(+47.5%) |
| Sep 2011 | - | -$15.52M(+507.1%) | -$25.02M(+234.8%) |
| Jun 2011 | - | -$2.56M(-198.1%) | -$7.47M(+2441.8%) |
| Mar 2011 | - | $2.61M(-127.3%) | -$294.00K(+167.3%) |
| Dec 2010 | $544.00K(-96.7%) | -$9.56M(-570.0%) | -$110.00K(-100.7%) |
| Sep 2010 | - | $2.03M(-56.0%) | $15.83M(-33.9%) |
| Jun 2010 | - | $4.62M(+65.7%) | $23.93M(+1.3%) |
| Mar 2010 | - | $2.79M(-56.3%) | $23.62M(+43.8%) |
| Dec 2009 | $16.43M(-58.7%) | $6.38M(-37.0%) | $16.43M(-61.0%) |
| Sep 2009 | - | $10.13M(+134.9%) | $42.10M(+22.7%) |
| Jun 2009 | - | $4.31M(-198.0%) | $34.32M(-0.6%) |
| Mar 2009 | - | -$4.40M(-113.7%) | $34.54M(-13.1%) |
| Dec 2008 | $39.76M(-169.4%) | $32.06M(+1263.5%) | $39.76M(-1872.4%) |
| Sep 2008 | - | $2.35M(-48.1%) | -$2.24M(-89.8%) |
| Jun 2008 | - | $4.53M(+453.8%) | -$21.90M(-45.3%) |
| Mar 2008 | - | $818.00K(-108.2%) | -$40.03M(-30.5%) |
| Dec 2007 | -$57.29M(+132.2%) | -$9.94M(-42.6%) | -$57.64M(-2.7%) |
| Sep 2007 | - | -$17.31M(+27.3%) | -$59.26M(+28.6%) |
| Jun 2007 | - | -$13.60M(-19.0%) | -$46.07M(+36.3%) |
| Mar 2007 | - | -$16.79M(+45.2%) | -$33.80M(+37.0%) |
| Dec 2006 | -$24.67M(-61.6%) | -$11.56M(+180.9%) | -$24.67M(-4.9%) |
| Sep 2006 | - | -$4.12M(+207.9%) | -$25.94M(-25.9%) |
| Jun 2006 | - | -$1.34M(-82.5%) | -$34.99M(-33.3%) |
| Mar 2006 | - | -$7.66M(-40.3%) | -$52.43M(-18.3%) |
| Dec 2005 | -$64.21M(-56.6%) | -$12.83M(-2.6%) | -$64.21M(-52.4%) |
| Sep 2005 | - | -$13.17M(-29.8%) | -$134.94M(-9.1%) |
| Jun 2005 | - | -$18.77M(-3.4%) | -$148.39M(+0.3%) |
| Mar 2005 | - | -$19.44M(-76.7%) | -$148.02M(+0.1%) |
| Dec 2004 | -$147.91M(+95.1%) | -$83.56M(+213.9%) | -$147.91M(+65.3%) |
| Sep 2004 | - | -$26.62M(+44.7%) | -$89.47M(+7.1%) |
| Jun 2004 | - | -$18.40M(-4.8%) | -$83.52M(+12.0%) |
| Mar 2004 | - | -$19.34M(-23.0%) | -$74.59M(-1.6%) |
| Dec 2003 | -$75.80M(+12.1%) | -$25.11M(+21.5%) | -$75.80M(-1.5%) |
| Sep 2003 | - | -$20.67M(+118.1%) | -$76.94M(+7.9%) |
| Jun 2003 | - | -$9.48M(-53.9%) | -$71.32M(-4.7%) |
| Mar 2003 | - | -$20.54M(-21.7%) | -$74.81M(+10.6%) |
| Dec 2002 | -$67.62M(+42.0%) | -$26.25M(+74.5%) | -$67.62M(+13.4%) |
| Sep 2002 | - | -$15.05M(+16.0%) | -$59.61M(+9.9%) |
| Jun 2002 | - | -$12.97M(-2.8%) | -$54.24M(+5.7%) |
| Mar 2002 | - | -$13.35M(-26.8%) | -$51.29M(+10.6%) |
| Dec 2001 | -$47.63M(+33.5%) | -$18.24M(+88.5%) | -$46.38M(+13.6%) |
| Sep 2001 | - | -$9.67M(-3.6%) | -$40.84M(+3.6%) |
| Jun 2001 | - | -$10.03M(+18.8%) | -$39.42M(+7.8%) |
| Mar 2001 | - | -$8.44M(-33.5%) | -$36.57M(+2.5%) |
| Dec 2000 | -$35.67M(+38.3%) | -$12.70M(+54.0%) | -$35.67M(+17.4%) |
| Sep 2000 | - | -$8.25M(+14.7%) | -$30.38M(+1.5%) |
| Jun 2000 | - | -$7.19M(-4.7%) | -$29.93M(+3.8%) |
| Mar 2000 | - | -$7.54M(+1.9%) | -$28.84M(+11.4%) |
| Dec 1999 | -$25.80M(+100.0%) | -$7.40M(-5.2%) | -$25.88M(+40.0%) |
| Sep 1999 | - | -$7.80M(+27.9%) | -$18.48M(+73.0%) |
| Jun 1999 | - | -$6.10M(+33.1%) | -$10.68M(+133.1%) |
| Mar 1999 | - | -$4.58M | -$4.58M |
| Dec 1998 | -$12.90M | - | - |
FAQ
- What is BioMarin Pharmaceutical annual operating income?
- What is the all time high annual operating profit for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual operating profit year-on-year change?
- What is BioMarin Pharmaceutical quarterly operating income?
- What is the all time high quarterly operating profit for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly operating profit year-on-year change?
- What is BioMarin Pharmaceutical TTM operating income?
- What is the all time high TTM operating profit for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM operating profit year-on-year change?
What is BioMarin Pharmaceutical annual operating income?
The current annual operating profit of BMRN is $474.21M
What is the all time high annual operating profit for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual operating income is $474.21M
What is BioMarin Pharmaceutical annual operating profit year-on-year change?
Over the past year, BMRN annual operating income has changed by +$316.12M (+199.95%)
What is BioMarin Pharmaceutical quarterly operating income?
The current quarterly operating profit of BMRN is $223.91M
What is the all time high quarterly operating profit for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly operating income is $223.91M
What is BioMarin Pharmaceutical quarterly operating profit year-on-year change?
Over the past year, BMRN quarterly operating income has changed by +$145.44M (+185.35%)
What is BioMarin Pharmaceutical TTM operating income?
The current TTM operating profit of BMRN is $619.61M
What is the all time high TTM operating profit for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM operating income is $619.61M
What is BioMarin Pharmaceutical TTM operating profit year-on-year change?
Over the past year, BMRN TTM operating income has changed by +$374.58M (+152.87%)